In the original article, there were mistakes in the legend for all of the figures as published. The source of the pictures cited in the article were not included. The correct legends appear below.
FIGURE 1
FIGURE 2
FIGURE 3
FIGURE 4
FIGURE 5
FIGURE 6
FIGURE 7
FIGURE 8
The sources for the figures have been added to the reference list, and the reference numbering has been updated to accommodate this. The new references are appear below.
The authors apologize for this error and state that authorization has been obtained from the author of each picture, and this does not change the scientific conclusions of the article in any way. The original article has been updated.
References
3.
PriorIALewisPDand MattosC.A Comprehensive Survey of Ras Mutations in Cancer. Cancer Res (2012) 72(10):2457–67. 10.1158/0008-5472.can-11-2612
4.
SimanshuDKNissleyDVand MccormickF.RAS Proteins and Their Regulators in Human Disease. Cell (2017) 170(1):17.
14.
HuiliLFeiJJiweiRTaoLYadongC.Research Advances on KRAS and Its Inhibitors. Acta Pharmaceutica Sinica (2020) 44(1):43–55.
20.
XinLYijunWand PingyuL. Recent Advancement In Targeting The KRASG12C Mutant For Cancer Therapy. Acta Pharmaceutica Sinica (2021) 56(2):374–82.
30.
FellJBFischerJPBaerBRBlakeJFBouhanaKBriereDMet alIdentification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer. J Med Chem (2020) 63(13):6679–93. 10.1021/acs.jmedchem.9b02052
33.
TranTHAlexanderPDharmaiahSAgamasuCand BaliusTE. The Small Molecule BI-2852 Induces A Nonfunctional Dimer Of KRASProc National Academy Sci. (2020) 117(7).
Summary
Keywords
KRAS mutation, targeted drugs, oncogene, inhibitor, oncology
Citation
Yang A, Li M and Fang M (2022) Corrigendum: The Research Progress of Direct KRAS G12C Mutation Inhibitors. Pathol. Oncol. Res. 27:1610250. doi: 10.3389/pore.2021.1610250
Received
09 December 2021
Accepted
29 December 2021
Published
24 February 2022
Volume
27 - 2021
Edited and reviewed by
József Timar, Semmelweis University, Hungary
Updates
Copyright
© 2022 Yang, Li and Fang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Min Li, doctorlimin@163.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.